European Archives - Page 582 of 1193 - European Medical Journal

Cardiovascular Autonomic Neuropathy May Predict Complications in Type 2 Diabetes

Cardiovascular autonomic neuropathy (CAN) might be a useful marker for long-term complications in patients with Type 2 diabetes (T2D)…

Artificial Pancreas App for Children with Type 1 Diabetes

An Android app has been created to manage insulin delivery in very young children affected by Type 1 diabetes…

Nurturing home-grown innovation in Europe

Europe is a front runner for pharmaceutical research and thought leadership Find out in what measure this is translating into home-grown innovation.

Sanofi and GSK seek COVID-19 vaccine approval

Sanofi and GSK are seeking regulatory approval for their adjuvanted protein-based COVID-19 vaccine, as a primary two-dose series and booster dose.

EMJ Oncology 10 [Supplement 4] 2022 Feature Image

Evolving the Role for Immunotherapy in Lung Cancer: Extensive-Stage Small Cell Lung Cancer and Unresectable Stage III Non-small Cell Lung Cancer

Lung cancer is classified into NSCLC (85% of patients) and SCLC (15%). NSCLC can be further classified histologically into three main type…

EMJ Oncology 10 [Supplement 4] 2022 Feature Image

EMJ Oncology 10 [Supplement 4] 2022

Expert discussion on the evolving role of immunotherapy in extensive-stage small cell lung cancer (ES-SCLC) from symposium sessions at the virtual 2020 International Association for the Study of Lung Cancer (IASLC) World Conference on Lung Cancer are reviewed in this article. Masahiro Tsuboi, National Cancer Centre Hospital East, Tokyo, Japan, chaired and opened the session by exploring the role of immuno-oncology in the management of unresectable Stage III non-small cell lung cancer (NSCLC).

Reacting to supply chain risks

The pharmaceutical supply chain is vulnerable to adverse events, and the pandemic has served as a reminder of how these networks can be tested. The industry has learned tough lessons from COVID-19 that must be translated into modernisation and improvements

Wayne Best, VMLY&R

Innovative tech, pharma supply chains and more

Marc and Helena chat with Wayne Best, Chief Creative Officer, VMLY&R, about his ‘I Will Always Be Me’ project for patients with motor neurone disease. Listen now!

EULAR Podcast Highlights: COVID-19, rheumatoid arthritis and ankylosing spondylitis

A review of the latest and most pertinent information from EULAR 2021 regarding COVID-19 for patients with rheumatic musculoskeletal…

EULAR Podcast Highlights: Latest treatment options for Psoriatic Arthritis

The novel data presented at EULAR 2021 highlights the latest treatment options and safety aspects for patients with psoriatic arthritis…